Merck's Keytruda Is First Checkpoint Inhibitor To Win US Approval Based On TMB Biomarker

 
• By Jessica Merrill
  
Athlete in action of high jump.
Keytruda clears a bar for use in TMB-high tumors • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip